NanoVibronix (NAOV) Stock Price, News & Analysis

Company Overview

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

Key Stats

• Today's Range: $0.57 to $0.62
• 50-Day Range: $0.51 to $0.77
• 52-Week Range: $0.46 to $1.52
• Volume: 49,083 shs
• Average Volume: 145,952 shs
• Market Capitalization: $2.18 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NAOV Stock Analysis - Frequently Asked Questions

How have NAOV shares performed this year?

NanoVibronix's stock was trading at $1.15 at the beginning of 2024. Since then, NAOV stock has decreased by 49.5% and is now trading at $0.5802.
View the best growth stocks for 2024 here.

How were NanoVibronix's earnings last quarter?

NanoVibronix, Inc. (NASDAQ:NAOV) issued its quarterly earnings data on Wednesday, November, 14th. The company reported ($0.11) earnings per share (EPS) for the quarter. The company earned $0.05 million during the quarter. NanoVibronix had a negative net margin of 93.80% and a negative trailing twelve-month return on equity of 101.17%.

When did NanoVibronix's stock split?

NanoVibronix's stock split on Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly minted shares were distributed to shareholders after the closing bell on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How do I buy shares of NanoVibronix?

Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of NanoVibronix own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NanoVibronix investors own include Exela Technologies (XELA), Assertio (ASRT), Meta Platforms (META), T2 Biosystems (TTOO), NIO (NIO), Senseonics (SENS) and SNDL (SNDL).

Company Calendar

• Last Earnings: 11/14/2018
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical appliances & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:NAOV
• CUSIP: N/A
• CIK: 1326706
• Web: www.nanovibronix.com
• Phone: (914) 233-3004
• Fax: 914-376-6111
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.23)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-3,710,000.00
• Net Margins: -93.80%
• Pretax Margin: -93.04%
• Return on Equity: -101.17%
• Return on Assets: -53.03%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.74
• Quick Ratio: 0.84

Sales & Book Value

• Annual Sales: $3.29 million
• Price / Sales: 0.66
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.95 per share
• Price / Book: 0.30

Miscellaneous

• Outstanding Shares: 3,752,000
• Free Float: 3,593,000
• Market Cap: $2.18 million
• Optionable: Not Optionable
• Beta: 1.62